MRTX•benzinga•
Earnings Preview For Mirati Therapeutics
Summary
Mirati Therapeutics (NASDAQ:MRTX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Mirati Therapeutics will report an earnings per share (EPS) of $-3.49.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 3, 2022 by benzinga